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DNA methylation is an important epigenetic modiﬁcation that can regulate gene expression following
environmental encounters without changes to the genetic code. Using Inﬁnium MethylationEPIC BeadChip
Arrays (850,000 CpG sites) we analysed for the ﬁrst time, DNA isolated from untrained human skeletal
muscle biopsies (vastus lateralis) at baseline (rest) and immediately following an acute (single) bout of
resistance exercise. In the same participants, we also analysed the methylome following a period of muscle
growth (hypertrophy) evoked via chronic (repeated bouts-3 sessions/wk) resistance exercise (RE) (training)
over 7-weeks, followed by complete exercise cessation for 7-weeks returning muscle back to baseline levels
(detraining), and ﬁnally followed by a subsequent 7-week period of RE-induced hypertrophy (retraining).
These valuable methylome data sets described in the present manuscript and deposited in an open-access
repository can now be shared and re-used to enable the identiﬁcation of epigenetically regulated genes/
networks that are modiﬁed after acute anabolic stimuli and hypertrophy, and further investigate the
phenomenon of epigenetic memory in skeletal muscle.
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Background Summary
A hallmark of eukaryotic cells is their ability to alter the expression of their inherited genetic code, in
order to adapt to external stimuli in an attempt to maintain functional homeostasis. In this regard,
epigenetics, referring to heritable changes in gene function that are not due to changes in the DNA
sequence itself1, is a mechanism by which modiﬁcations at speciﬁc genomic sites (predominantly
chromatin and DNA) have the ability to alter fundamental DNA-based processes including transcription,
translation and DNA repair. DNA methylation is an epigenetic mark that, via speciﬁc enzymes,
incorporates a methyl group to the ﬁfth position of the pyrimidine ring of a cytosine (5mC) in a cytosine-
guanine base pairing (CpG), attenuating the performance of transcriptional apparatus and producing a
reduction in the expression of speciﬁc gene transcripts2.
Seminal in-vivo work in human skeletal muscle showed that acute aerobic exercise (80% VO2 max
until 1674 kj/400 kcal was expended) rapidly alters promotor DNA methylation in important
mitochondrial related transcripts (PGC1α, PDK4, TFAM and PPARδ), and was associated with a
time-dependent increase in their transcript expression, work that added to previous insights into the role
of DNA methylation during aerobic based interventions3,4. The same authors further conﬁrmed these
ﬁndings, where electrically stimulated (a set equated to 0.3 s trains of 25 Hz, 0.1 ms impulses, repeated
every second for 5-mins, with sets repeated every 10-mins for 1 h) mouse soleus muscle produced
signiﬁcant reductions in promotor methylation (hypomethylation) 45-min post stimulation, that was met
with signiﬁcant increases in gene expression of PGC1α, PDK4 and PPARδ 180-min later5. Similar
ﬁndings having since been replicated in rodents, where mice subjected to an acute bout of endurance
exercise (35 rpm on a 3.0 cm rotarod machine, increasing to 45 rpm over a 60-min period), displayed
increased hydroxy-methylation of the PGC1α promotor that correlated to increased basal mRNA
expression6. Furthermore, moderate intensity exercise has also been shown to produce alterations in
promotor methylation, where 120-mins of cycling (60% VO2 max) resulted in hypermethylation of
FABP3 and COX4L1 creating a corresponding reduction in gene expression in healthy adult human
subjects7. Collectively, these data suggest that changes in promotor methylation are associated with
alterations in gene transcript expression following aerobic exercise. However, at present there are a
limited number of studies that investigate the effects of resistance exercise on DNA methylation in
skeletal muscle tissue. Currently, there have been studies investigating changes in methylation of
leukocyte DNA following 8-weeks of resistance exercise in healthy male subjects8. Following conﬁrmation
that resistance exercise induced large scale methylome and transcriptome alterations in the leukocytes,
the authors identiﬁed two key anabolic transcripts, growth hormone-releasing hormone (GHRH) and
ﬁbroblast growth hormone 1 (FHG1), as displaying an inverse relationship, where reductions in
methylation were associated with enhanced gene expression8. In skeletal muscle, the epigenome was
examined following a short-term period (9 days) of either high-fat feeding or high-fat feeding plus
resistance exercise, displaying a preferential hypermethylated proﬁle following high-fat feeding and a
hypomethylated signature following high-fat feeding plus resistance exercise9. Closer analysis identiﬁed
two transcripts that showed a distinct inverse relationship between gene expression and promotor DNA
methylation following high-fat feeding plus resistance exercise9. Despite these ﬁndings, and further
reports identifying the importance of promotor DNA methylation in muscle mass regulation following
muscle atrophy10, and studies suggesting muscle cells retain DNA methylation over several daughter
populations when encountering early proliferative-life inﬂammation (TNF-alpha)11,12, there is distinct
lack of current research elucidating the DNA methylation changes in skeletal muscle tissue using the
latest genome-wide array techniques following acute resistance exercise alone or after chronic resistance
exercise. There are also currently no studies investigating the effect of detraining or later retraining on the
skeletal muscle methylome in humans.
However, in a recent multi-stage, in-vivo within-subjects experiment, eight healthy previously un-
trained male subjects performed an acute bout of resistance exercise (acute RE), followed by a progressive
7-week resistance training programme (training) to evoke muscle hypertrophy. Subjects then completely
ceased exercise for a period of 7-weeks to return muscle size back towards pre-exercise levels (detraining),
followed by a further and ﬁnal period of 7-weeks resistance exercise to evoke hypertrophy (retraining).
Fasted biopsies were obtained at baseline and post-acute RE, training, detraining and retraining. DNA
methylation was detected via the use of the Inﬁnium
®
MethylationEPIC BeadChip Array (Illumina, Inc.,
California, United States) that analyses over 850,000 CpG sites of the human epigenome. The EPIC
BeadChip provides dense coverage of gene regions including CpG islands, RefSeq genes, ENCODE
transcription factor binding sites and FANTOM5 enhancers. Furthermore, the relatively new array
technology covers over 90% of the previous array model (HumanMethylation 450 K BeadChip, Illumina,
United States), with an added 350,000 CpG sites of regions identiﬁed as potential enhancers by
FANTOM513 and ENCODE14. Collectively, the array provides one of the most comprehensive but
discernible explorations of known CpG sites in the human genome15. Thus, utilising this array in our
experimental model, we provide for the ﬁrst time, a comprehensive and extensive data descriptor of the
human methylome after both acute and chronic resistance exercise training, detraining and retraining.
In the primary research paper16, in which the present manuscript serves as a data descriptor, we
identiﬁed that 30 min following a single/acute bout of resistance exercise (acute RE), resulted in extensive
modiﬁcations to the human methylome, where 17,884 CpG sites were signiﬁcantly modiﬁed (P ≤ 0.05),
preferentially favouring reduced DNA methylation (hypomethylation), where 10,284 CpG sites were
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hypomethylated versus 7,600 CpG sites that were hypermethylated. Furthermore, we reported large
alterations in DNA methylation patterns following chronic resistance exercise induced hypertrophy
(6.5 ± 1% increase in lower limb lean mass vs. baseline) with 17,365 signiﬁcantly differentially modiﬁed
CpG sites (9,153 hypomethylated and 8,212 hypermethylated). Followed by detraining where muscle
returned back to baseline levels after complete cessation of resistance exercise with 17,529 signiﬁcantly
modiﬁed CpG sites (8,891 hypomethylated and 8,636 hypermethylated) and ﬁnally a subsequent period
of retraining induced hypertrophy (12.4 ± 1.3% increase in lower limb mass vs. baseline and +5.9% ±
1% vs. the earlier period of training induced hypertrophy) where 27,155 CpG sites were signiﬁcantly
modiﬁed (18,816 hypomethylated and 8,339 hypermethylated). Demonstrating the largest increase in
lean mass of the lower limbs during retaining was associated with the largest increase in hypomethylation
of the genome (18,816 CpG sites signiﬁcantly modiﬁed after later retraining versus 9,153 CpG sites after
earlier training). Resulting in 69% of the differentially modiﬁed CpG sites during retaining favouring
hypomethylation versus hypermethylation. We identiﬁed a number of genes (AXIN1, GRIK2, CAMK4,
TRAF1) as hypomethylated at the DNA level that also demonstrated enhanced gene expression after
training. These genes also maintained their hypomethylated status even during detraining where muscle
mass returned to control levels, indicating a memory of these genes methylation signatures following
earlier training induced hypertrophy. Further, we identiﬁed several genes (UBR5, RPL35a, HEG1,
PLA2G16, SETD3) that displayed hypomethylation and enhanced gene expression following earlier
training induced hypertrophy, positively correlating with lean mass increases, with some of these genes
demonstrating the largest increases in hypomethylation, gene expression and muscle mass after later
retaining induced hypertrophy, indicating an epigenetic memory in these genes. Finally, there were also a
group of epigenetically ‘sensitive’ genes (GRIK2, TRAF1, BICC1, STAG1) following acute resistance
exercise demonstrating hypomethylation after a single bout of exercise that was maintained 22 weeks
later with the largest increase in gene expression and muscle mass after retraining. Overall, we identiﬁed
an important epigenetic role for a number of largely unstudied genes in muscle hypertrophy/memory. In
the present manuscript we provide a detailed description of the methodological approach used to analyse
this genome wide DNA methylation data set in doing so, we hope to encourage the wider data sharing
and reuse use of this valuable data set for future comparative/bioinformatic analysis investigating the
epigenetic mechanisms of skeletal muscle adaptation and memory.
Methods
Human Participants and Ethical Approval
Ethical approval for the study was granted by the NHS West Midlands Black Country, UK, Research
Ethics Committee (NREC, UK approval no. 16/WM/0103). Eight healthy males gave written, consent to
participate in the study, following successful completion of a readiness to exercise questionnaire and a
pre-biopsy screening as approved by a physician. One participant withdrew from the study at
experimental week 17 of 21, for reasons unrelated to this investigation. However, consent allowed
samples to be analysed prior to withdrawal, therefore for this participant all conditions were included
except the ﬁnal retraining condition.
Experimental Design
Using a within subject design eight previously untrained male participants (27.6 ± 2.4 yr, 82.5 ± 6.0 kg,
178.1 ± 2.8 cm, means ± SEM) completed an acute bout of resistance exercise (acute RE), followed by 7
weeks (3d/week) of resistance exercise (training), 7 weeks of exercise cessation (detraining) and a further
period of 7 weeks (3d/week) resistance exercise (retraining). Graphical representation of experimental
design is provided in Fig. 1. Whole-body fan beam dual-energy x-ray absorptiometry (DEXA), strength of
the quadriceps via dynamometry and muscle biopsies from the vastus lateralis for RNA and DNA
isolation were obtained at baseline, after 7 weeks training (beginning of week 8), 7 weeks detraining
(end of week 14) and 7 weeks retraining (beginning of week 22), as described in our original paper16. A
muscle biopsy was also obtained 30 min after acute RE prior to 7 weeks resistance exercise/training.
Genome-wide analysis of DNA methylation was performed via Illumina EPIC array (> 850,000 CpG
sites- detailed below) for participants across all conditions (n = 8 baseline, acute, training, detraining,
n = 7 retraining).
Acute resistance exercise, training, detraining and retraining
Descriptive details of exercise and biopsy procedures are taken from our primary paper16. Brieﬂy,
untrained male subjects initially performed an exercise familiarization week, in which participants
performed all exercises with no/low load to become familiar with the exercise movements (detailed
below). In the ﬁnal session of the familiarization week, the load that participants could perform 4 sets of
8-10 repetitions for each exercise was assessed. Due to participants being un-customized to resistance
exercise, assessment was made on competence of lifting technique, range of exercise motion and verbal
feedback. Subsequently, starting load was set for each participant on an individualised basis. Three to four
days later, participants then undertook a single bout of lower limb resistance exercise (acute RE) followed
by biopsies 30-mins post exercise. Following this single bout of acute RE they then began a chronic
resistance exercise program (training), completing 60-min training sessions (Monday-Wednesday-
Friday), for 7 weeks, with 2 sessions/week focusing on lower limb muscle groups (Monday and Friday)
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and the third session focusing on upper body muscle groups (Wednesday). Lower limb exercises
included; behind head barbell squat, leg press, leg extension, leg curl, Nordic curls, weighted lunges and
calf raises. Upper limb exercises included, ﬂat barbell bench press, machine shoulder press, latissimus
dorsi pull down, bent over dumbbell row and triceps cable extension. To ensure progression in
participants with no previous experience of resistance exercise, a progressive volume model was
adopted17 in which investigators regularly assessed competency of sets, reps and load of all exercises.
Brieﬂy, exercises were performed for 4 sets of 10 reps in each set, ~90-120 s in between sets and ~3 mins
between exercises. When participants could perform 3 sets of 10 repetitions without assistance and with
the correct range of motion, load was increased by ~5-10% in the subsequent set and participants
continued on this new load until further modiﬁcation was required. Where subjects failed to complete 10
full repetitions (usually for their ﬁnal sets), they were instructed to reduce the load in order to complete a
full repetition range for that set or the subsequent set. Total weekly volume load was calculated as the sum
of all exercise loads;
Total exercise volume kgsð Þ ¼ ðExercise load kgsð Þ  No: of RepsÞ  No: Sets
Load data following single acute RE stimulus and training, detraining and retraining are included in detail
in our original paper16. Training and retraining programs were conducted in an identical manner, with
the same exercises, program layout (same exercises on same day), sets and repetition pattern, as well as
rest between sets and exercises. During the 7-week detraining phase, participants were instructed to
return to habitual pre-intervention exercise levels and not to perform any resistance training. Regular
verbal communication between researcher and participant ensured subjects followed these instructions. A
trainer was present at all resistance exercise sessions to enable continued monitoring, provide verbal
encouragement and to ensure sufﬁcient progression. No injuries were sustained throughout the exercise
intervention.
Muscle Biopsies and Sample Preparation
At baseline, 30- mins post-acute resistance exercise (RE) and after 7 weeks training (beginning of week 8),
7 weeks detraining (end of week 14) and 7 weeks retaining (beginning of week 22) (Fig. 1), a conchotome
muscle biopsy was obtained at rest from the vastus lateralis muscle of the quadriceps from each
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Figure 1. Schematic representation of human resistance exercise study and methylome-wide
bioinformatics pipeline. Muscle biopsies were obtained in previously untrained male participants following 7-
weeks of chronic resistance training (loading), 7-weeks exercise cessation/detraining (unloading) and a later 7-
week period of chronic retraining (reloading). A biopsy was also obtained following the ﬁrst acute (single)
bout of resistance training (acute RE). The schematic shows the work-ﬂow utilised to generate genome-wide
DNA methylation proﬁles in human participants, the methodological approach and the assays utilised.
Bioinformatical analysis was performed in Partek Genomic Suite (Partek Genomic Suite, V6.6, Missouri, USA).
Schematic adapted from our primary paper16. Licensed under the Creative Commons Attribution 4.0
International Public License. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
legalcode.
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participant, avoiding areas of immediate proximity to previous incisions. Muscle biopsy procedures were
performed following an overnight fast. Tissue samples were carefully dissected using a sterile scalpel on a
sterile petri-dish, where, in the unlikely event of any fat, ﬁbrous or other stroma tissue, samples were
removed of these. Tissue samples were subsequently immediately snap frozen in liquid nitrogen before
being stored at −80 °C for later DNA isolation.
Isolation of DNA and Bisulﬁte Treatment
All samples were isolated using a commercially available DNA isolation kit (DNeasy Blood and Tissue
Kit; Qiagen, United Kingdom) in accordance with manufacturers’ instructions. Samples were collected
from −80 °C and immediately kept on ice before being immersed in 200 μl of DNA homogenate buffer
(180 μl of ATL buffer and 20 μl of proteinase k) and homogenised at 6,000 rpm 40-secs (MagNA Lyser
Instrument, Roche Life Sciences, UK). This step was repeated 3 times with 5 min on ice between
homogenisations, to ensure total disruption of muscle cells, and the release of genomic DNA while
avoiding its degradation. Suspension was supplemented with 200 μl of AL buffer before being incubated
at 56 °C for 10-mins. Molecular grade ethanol (200 μl of>96% pure) was subsequently added to the
suspension before being brieﬂy vortexed and aliquoted into spin columns placed in 2 ml collection tubes
(DNeasy Mini Spin Colum, DNeasy Kit, Qiagen). Spin columns were centrifuged at 6,000 g for 1-min,
ﬂow through discarded and 500 μl of buffer AW1 added to the spin column and centrifuged at 6,000 g for
1-min. Buffer AW2 was then added to the spin column and centrifuged at 20,000 g for 3-min. All ﬂow
through was discarded and spin columns were placed in new RNA/DNA free tubes (RNase-free
Microfuge Tubes, AmbionTM, ThermoFisher Scientiﬁc, United States), before 50 μl of elution reagent
(buffer AE) was added directly to the spin column and centrifuged at 6,000 g for 1-min. This elution step
was repeated to yield a total DNA suspension of 100 μl per original sample. Eluted suspension was then
analysed for quality and quantity (Supplementary Table 1) via ultra violet spectroscopy (Nanodrop 2000,
ThermoFisher Scientiﬁc, United States).
For bisulﬁte conversion (EZ DNA Methylation Kit, Zymo Research, CA, United States), 5 μl of
M-Dilution Buffer was added to 500 ng of isolated DNA, and distilled water (dH20) was added where
applicable, to yield a total suspension of 50 μl, before samples were incubated for 15-mins at 37 °C. In
each sample 100 μl of prepared CT Conversion Reagent was added and incubated in the dark overnight
(16-hrs) at 50 °C. Following this incubation, samples were stored on ice for 10-mins. Four-hundred μl of
M-Binding Buffer was added to each well, before experimental samples were added and mixed.
Suspension was centrifuged at 3,000 g for 5-mins, ﬂow-through was discarded and 500 μl of M-Wash
Buffer was added and centrifuged at 3,000 g for 5-mins. M-Desulphonation Buffer (200 μl) was added to
the suspension and left to incubate at room temperature for 15-20-mins before being centrifuged at 3,000
g for 5-mins. Two wash buffer stages were then performed, where 500 μl of M-Wash Buffer was added to
the suspension and centrifuged at 3,000 g for 5 and 10-mins, respectively. To elute the sample, the silicon
plate was placed onto an Elution Plate and 30 μl of M-Elution Buffer was added directly to the matrix of
each well and spun at 3,000 g for 3-mins.
Inﬁnium MethylationEPIC BeadChip Array Ampliﬁcation. All methylome wide experiments were
performed in alignment with Illumina manufacturer instructions for the Inﬁnium MethylationEPIC
BeadChip Array. All samples were treated identically and in the same work ﬂow to avoid confounding
batch effects. Four μl of bisulﬁte converted DNA (BCD) was transferred from the bisulﬁte conversion
plate in to corresponding wells of the MSA4 plate, where 20 μl of MA1 and 4 μl of 0.1 N NaOH were
added before plate was vortexed (1600 rpm for 1-min), pulse centrifuged (280 g) and left to incubate at
RT for 10-mins. Samples within this place then had 68 μl of RPM and 75 μl of MSM added before a
further round of vortex and centrifugation was performed (identical to above). Samples were
subsequently left in a 37 °C hybdrization oven overnight (20-24 hrs) to allow for ampliﬁcation.
Fragmentation, Precipitation and Resuspension of Ampliﬁed DNA. FMS (50 μl) was added to each
well of the MSA4 before being vortexed (1600 rpm for 1-min), centrifuged (280 g) and incubated (37 °C
for 1-hr) to fragment DNA. An endpoint fragmentation was used to avoid over-fragmentation. Following
incubation, 100 μl of PM1 and 300 μl of 2-propanol were added to each well interspersed with vortexing
(1600 rpm for 1-min), incubation (37 °C for 5-mins) and centrifugation (280 g for 1-min). MSA4 plate
was subsequently mixed via inversion (at least 10 times) incubated at 4 °C for 30-mins and centrifuged at
3000 g at 4 °C for 20-mins. The subsequent supernatant liquid was decanted out of wells and left at room
temp for 1 h to dry the residual pellet. Following precipitation, each pellet in each well was resuspended in
46 μl of RA1 and incubated at 48 °C for 1-h. Finally, each resuspended pellet was vortexed for 1-min (at
18000 rpm) and pulse centrifuged at 280 g.
Hybdrization to BeadChip, Extension and Staining. Fragmented DNA residing on the MS4A plate
was incubated at 95 °C for 20-mins to denature experimental samples before being left to stand at room
temp for 30-mins and pulse centrifuged at 280 g. DNA was subsequently prepared for transfer and
precisely loaded onto a working BeadChip. BeadChips were loaded into the Illumina Hyb Chamber and
placed for over-night incubation at 48 °C for 16-hrs, before being washed (gentle agitation in 200 ml of
PB1) and readied for BeadChip staining. Assembled ﬂow-through chambers were loaded into a chamber
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rack where single based-extension occurred of each ﬂow through assembly. This single base-extension
was performed at 44 °C via the addition of the following reagents: 150 μl of RA1 with incubation of 30-
secs (repeated 5 times), 450 μl of XC1, 450 μl of XC2, 200 μl of TEM and 450 μl of 95% formamide/1 mM
EDTA (repeated). Each ﬂow-through assembly was incubated for 5-mins, before 450 μl of XC3 was added
(repeated). Staining of assemblies was performed in 5 repeated cycles of the following: addition of 250 μl
of STM to each ﬂow-through assembly (10-mins incubation), 450 μl of XC2 incubated for 1-min
Figure 2. Complete quality control analysis completed on methylome-wide array. (a). Principal component
analysis of un-normalized samples where each sample is represented by a dot. Ellipsoids have been created as
2SD’s from the centroid for each time/condition. (b). Frequency plot by lines, with beta values are on the
horizontal axis and their frequencies on the vertical axis (un-normalised samples). (c). Distribution of beta
values across the samples and conditions by a box-and-whiskers plot (un-normalized samples) and conditions
by a box-and-whiskers plot (un-normalized samples). (d). Density plot of the raw probe intensities/signals after
normalization demonstrating all unmethylated and methylated signals were above 11.5. (e). Plot of detection P
values (samples normalized) with an average of 0.0000257, well below 0.01 recommended. (f). Principal
component analysis (PCA) (samples normalized) where each sample is represented by a dot. Ellipsoids have
been created as 2SD’s from the centroid for each time/condition. PCA was derived and adapted from original
analysis in our primary paper16. Licensed under the Creative Commons Attribution 4.0 International
Public License. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/legalcode.
(g). Frequency plot by lines, with beta values are on the horizontal axis and their frequencies on the vertical
axis, representing the distribution of intensity for each probe (samples normalised) Two samples were
identiﬁed as 2SD’s from the centroid (in Fig. 2A above) and as showing differential distribution patterns and
were removed from further down-stream analysis (annotated via ‘X’). Histogram derived and from original
analysis in our primary paper16. Licensed under the Creative Commons Attribution 4.0 International
Public License. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/legalcode.
(h). Frequency plot by bars, with beta values are on the horizontal axis and their frequencies on the vertical axis
(samples normalized). (i). Distribution of beta values across the samples and conditions by a box-and-whispers
plot (samples normalized). (j). PCA with ellipsoids 2SD’s from the centroid for time/condition, after removal of
two samples that were 2SD’s from the centroid (in Fig. 2A above) and as showing differential distribution
patterns (Fig. 2B above). Baseline = biopsy at rest, Acute Loading = Acute RE, Chronic Loading = Training,
unloading = Detraining, Chronic Reload = Retraining.
www.nature.com/sdata/
SCIENTIFIC DATA | 5:180213 | DOI: 10.1038/sdata.2018.213 6
(repeated) and left to stand for 5-mins. To wash staining reagents, BeadChips were gently submerged and
agitated initially in PB1 (310 ml per 8 BeadChips), and then in XC4 (same total amount of reagent), with
a 5-min delay in between the use of both cleaning buffers. Finally, washed BeadChips were left to dry for
50-55-mins before being taken for BeadChip imagery, using the Illumina iScan® System (Illumina, United
States).
Following DNA methylation quantiﬁcation via MethylationEPIC BeadChip array, raw IDAT ﬁles were
processed on Partek Genomic Suite V.6.6 (Partek Inc. Missouri, USA). Upon import of the data, the
MethylationEPIC_v-1-0_B2.bpm manifest ﬁle was used to ﬁlter out known cross-reactive probes and
SNPs. Prior to normalisation we undertook principle component analysis (PCA) (Fig. 2a), density plots
(Fig. 2b) and box/whisker plots (Fig. 2c) of the un-normalised samples. Following this, background
normalisation was performed via the Subset-Quantile Within Array Normalisation (SWAN) method, as
previously described18, to generate ß-values for CpG DNA methylation at>850,000 loci of the human
epigenome. We also undertook density plots of the raw intensities/signals of the probes (Fig. 2d) that
demonstrated all methylated and unmethylated signals were over 11.5, and the the difference between
median methylation and median unmethylated signal was less than 0.5 as suggested in19. We also
calculated the average detection p-value (0.0000257 across all samples; Fig. 2e), which was below that
recommended in the Oshlack workﬂow, of 0.0119. Following normalisation, we undertook principle
component analysis (PCA) (Fig. 2f), density plots by lines (Fig. 2g) and by bars (Fig. 2h) as well as box
and whisker plots (Fig. 2i) of normalised samples. Outlier samples were detected using principle
component analysis (PCA) and analysing the normal distribution of ß-values. Outliers were then
removed if they fell outside 2 standard deviations (SDs) from the centroid (in Fig. 2f) using ellipsoids as
well as showing different distribution patterns to the samples of the same condition (Fig. 2g).
Data Records
Raw IDAT ﬁles for MethylomeEPIC BeadChip of the human epigenome were deposited in the publicly
available functional genomics data repository, Gene Expression Omnibus (GEO) and have been assigned
GEO accession and reference number GSE114763 (Data Citation 20).
Technical Validation
Validation of In-Vivo Changes in Muscle Morphology
As skeletal muscle samples were obtained from in-vivo milieu, it is important to report the morphological
adaptations that occurred in order to justify and validate the intervention. Description of subject
characteristics, including changes to lower limb lean mass and muscular strength, are provided in Table 1
(available online only), and can be found in the primary manuscript16. Brieﬂy, we report, via dual-energy
x-ray absorptiometry (DEXA), that signiﬁcant increases in muscle mass of the lower limb were attained
following 7 weeks of training, that returned towards baseline control levels upon detraining.
Subsequently, 7-weeks of secondary exposure to resistance exercise (retraining) induced a further
increase in muscle mass.
Age Height
(cm)
Weight
(kg)
Lean Mass (kg) Isometric Voluntary Contraction (Nm)
Baseline Training
(Loading)
Cessation/
Detraining
(Unloading)
Retraining
(Reloading)
Baseline Training
(Loading)
Cessation/
Detraining
(Unloading)
Retraining
(Reloading)
Participant
1
39 175 72.8 17.21 18.77 17.62 19.55 223.4 245.2 217.6 257.6
Participant
2
19 182.2 72.2 20.28 22.50 21.20 23.91 336.9 352.6 327.3 399.1
Participant
3
29 177.2 78.6 20.00 21.00 19.88 21.81 274.2 344.1 319.2 370.3
Participant
4
27 196 117.8 24.14 25.60 24.48 26.00 390.0 439.3 364.3 452.6
Participant
5
32 176.4 79.0 19.54 20.77 20.31 21.95 304.6 345.9 349.2 380.5
Participant
6
30 174.4 74.0 19.52 20.48 19.93 22.31 310.6 320.2 315.7 332.5
Participant
7
23 172.0 68.0 15.58 16.12 15.47 17.43 233.3 224.2 219.8 254.4
Participant
8
32 171.5 97.8 16.94 18.64 17.52 – 244.7 224.5 198.8 –
Table 2. Sample information for Methylation EPIC Bead Chip Array in human skeletal muscle
following acute resistance (acute RE) exercise, 7-weeks of resistance training (loading), 7-weeks
exercise cessation/detraining (unloading) and 7-weeks of re-training (reloading).
www.nature.com/sdata/
SCIENTIFIC DATA | 5:180213 | DOI: 10.1038/sdata.2018.213 7
Quality Control of Isolated DNA
Samples were assessed for quantity and quality of isolated DNA from original muscle samples via
UV spectroscopy (Nanodrop 2000, ThermoFisher Scientiﬁc, United States), where the mean yield of
isolated DNA was 7.8 μg (±4.4 SD) and quality indicated via absorbency at 260/280 UV wavelength was
1.87 (±0.10 SD).
Quality Control of DNA Methylation Probes
Principal Component Analysis (PCA; Fig. 2f) and frequency plots by lines (Fig. 2g) were performed to
detect for probe outliers. Following analysis, two experimental samples (relating to one ‘baseline’ and one
‘unloading’ sample; SkM_Epi_Mem_1 and SkM_Epi_Mem_39, respectively see GSE database and
Table 2 for further detail) were identiﬁed as outliers and thus were removed from further down-stream
analysis. All other samples were deemed sufﬁcient and passed quality control validations. In relation to
the heterogeneity of tissue samples, it may be plausible that a small proportion of other non-muscle cells
exist in these derived samples. However, PCA analysis suggests sample homogeneity was consistent in the
experimental groups and therefore downstream analysis was representative of skeletal muscle tissue and
its niche.
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